EX-99.3 VOTING TRUST 2 meeting.txt SHAREHOLDER MEETING RESULTS THE FRANCE GROWTH FUND, INC. Annual Meeting of Stockholders Held June 24, 2003 Final Report of the Inspector of Election I, the undersigned, duly appointed Inspector of Election at the Annual Meeting of Stockholders (the "Meeting") of The France Growth Fund, Inc. (the "Fund"), held on June 24, 2003, hereby certify that: 1) Before entering upon the discharge of my duties as Inspector of Election at the Meeting, I took and signed an Oath of Inspector of Election. 2) The Meeting was held at the offices of UBS Global Asset Management (US) Inc., 1285 Avenue of the Americas, New York, New York, at 10:00 a.m., New York City time, on June 24, 2003, pursuant to notice duly given. 3) At the close of business on March 31, 2003, the record date for the determination of stockholders entitled to vote at the Meeting, there were issued and outstanding 12,072,000 shares of the Fund's common stock, each share being entitled to one vote, constituting all of the outstanding voting securities of the Fund. 4) At the Meeting, the holders of 11,371,561 shares of the Fund's common stock were represented in person or by proxy, constituting a quorum. 5) The undersigned canvassed the votes of the stockholders cast by ballot or proxy on the matters presented at the Meeting. 6) At the Meeting, the vote on the election of three (3) Class III directors to serve for a term expiring on the date on which the Annual Meeting of Stockholders is held in 2006 was as follows: In Favor Withheld Thomas C. Barry 7,085,215 3,775,762 Gregory L. Melville 6,812,241 4,048,736 Moritz Sell 6,810,712 4,050,265 7) At the Meeting, the vote on a stockholder proposal asking the Board of Directors of the Fund to promptly take the steps necessary to liquidate the Fund or otherwise enable stockholders to realize net asset value for their shares was as follows: For Against Abstain 5,459,954 2,453,085 40,740 IN WITNESS WHEREOF, I have made this Final Report and have hereunto set my hand this 27th day of June 2003. IVS Associates, Inc. Creighton D. Dunlop